Investor relations News releases Danish News release archive 2009 in Danish 2008 in Danish 2007 in Danish 2006 in Danish 2005 in Danish 2004 in Danish Presentations Finance Annual reports Quarterly reports Accounting policies Share information Share performance Latest trades Investment calculator Historical lookup WAP solution Ownership Warrant programmes Insider announcements Analyst coverage Corporate governance Management system Annual general meeting Articles of association Incentive plans Remuneration policy for the Board of Directors Remuneration policy for the Executive Management Risk profile Internal control and risk management systems Share purchase programme Event calendar About us Fact sheet Management Board of Directors Executive Management Vice President Group Partners Abbott Eli Lilly Janssen Pharmaceutica Affiliates NsGene A/S Atonomics A/S ZGene A/S Sophion Bioscience A/S Location Recommended hotels R&D pipeline Introduction to Huntexil Mailing list IR Contact Research & Development Drug Development Huntexil Mode of action Development programme Presentations Tesofensine ABT-894 ACR343 ACR325 ABT-560 NSD-788 NSD-721 Drug Discovery Target-based drug discovery GABA receptors Glutamate receptors Nicotinic receptors Potassium channels Monitoring ion channels ISP-based drug discovery Dopaminergic stabilizers Partners Abbott Laboratories Eli Lilly Janssen Pharmaceutica Scientific articles CNS diseases Ion channel research Scientific events About us Fact sheet Management Board of Directors Executive Management Vice President Group Partners Abbott Astellas Eli Lilly Company Affiliates